The cGMP-4 facility will further strengthen the company's ability to serve global partners
New Bay Area building marks significant progress as part of $32 billion US investment projected to create $43 billion in economic value
The facility has been designed with a dual focus on efficiency and sustainability
He has successfully led the development of 15 approved drugs worldwide across various therapeutic areas over his more than 20-year career
This PSD-3, the first pharmaceutical spray dryer built by GEA for OEB-5 products, sets new standards for high-containment pharmaceutical spray drying
As with any medicine, the MHRA will keep the safety of gepotidacin under close review
WIDAPLIK is the first and only FDA-approved triple combination medication for use as an initial therapy in patients likely to need multiple drugs to achieve blood pressure goals
Subscribe To Our Newsletter & Stay Updated